Systematic overview of co-proxamol to assess analgesic effects of addition of dextropropoxyphene to paracetamol
Authors:
Abstract
Objective: To evaluate the comparative efficacy and tolerability of paracetamol-dextropropoxyphene combination and paracetamol through a systematic overview of randomised controlled trials. Design: Systematic retrieval of trials of paracetamol-dextropropoxyphene, paracetamol, and placebo to allow pooling of results from head to head comparison trials and single active placebo controlled trials. Subjects: 2231 patients with postsurgical pain, arthritis, and musculoskeletal pain reported in 26 randomised controlled trials. Main outcome measures: Sum of difference in pain intensity; response rate ratio and difference in response rate with response defined as moderate to excellent pain relief; and rate ratio and rate difference of side effects. Results: The difference in pain intensity between paracetamol-dextropropoxyphene and paracetamol was 7.3% (95% confidence interval −0.2 to 14.9). The response rate ratio for the combination and paracetamol was 1.05 (0.8 to 1.3) on the basis of the head to head trials. Indirect comparisons produced quantitatively consistent results. Compared with placebo, the combination produced more dizziness (3.1; 1.1 to 8.9) whereas paracetamol resulted in more drowsiness (1.8; 1.1 to 2.9). Conclusion: On the basis of data on analgesic efficacy and acute safety in both head to head and indirect comparisons, there is little objective evidence to support prescribing a combination of paracetamol and dextropropoxyphene in preference to paracetamol alone in moderate pain such as that after surgery. Key messages: Combinations of paracetamol with centrally acting analgesics are widely used, accounting for 73% of all prescriptions for paracetamol in a recent hospital survey in the United Kingdom The combination of paracetamol (650 mg) with dextropropoxyphene hydrochloride (32.5 mg) is particularly popular In both head to head and indirect comparisons of paracetamol and the combination, the combination was no better than paracetamol on its own Since the total number of patients in the few published head to head comparisons was modest, small differences in effect cannot be excluded but these are unlikely to be of clinical importanceKeywords
This publication has 31 references indexed in Scilit:
- Improving the Quality of Reporting of Randomized Controlled TrialsJAMA, 1996
- Effektivität von Oleum menthae piperitae und von Paracetamol in der Therapie des Kopfschmerzes vom SpannungstypDer Nervenarzt, 1996
- A general parametric approach to the meta‐analysis of randomized clinical trialsStatistics in Medicine, 1991
- Augmentation of Acetaminophen Analgesia by the Antihistamine PhenyltoloxamineThe Journal of Clinical Pharmacology, 1989
- Comparative study of flurbiprofen, zomepirac sodium, acetaminophen plus codeine, and acetaminophen for the relief of postsurgical dental painThe American Journal of Medicine, 1986
- Analgesic Effect of Acetaminophen, Phenyltoloxamine and Their Combination in Postoperative Oral Surgery PainPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1984
- A 12‐hour Evaluation of the Analgesic Efficacy of Diflunisal, Propoxyphene, A Propoxyphene‐Acetaminophen Combination, and Placebo in Postoperative Oral Surgery PainPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1982
- Postsurgical Pain: Zomepirac Sodium, Propoxyphene/‐Acetaminophen Combination, and PlaceboThe Journal of Clinical Pharmacology, 1981
- Evaluation of Acetaminophen, Propoxyphene, and Their Combination in Office PracticeThe Journal of Clinical Pharmacology, 1979
- Propoxyphene HydrochlorideJAMA, 1970